Results 161 to 170 of about 21,764,403 (203)
Biopharmaceutics Classification System (BCS) An overview
Dr Pooja Agrawal +5 more
openaire +1 more source
Biplab De, Somenath Routh
openaire +1 more source
The biopharmaceutical classification system - impact for drug development
openaire +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The utility of rat jejunal permeability for biopharmaceutics classification system
Drug Development and Industrial Pharmacy, 2009The biopharmaceutical classification system has been developed to provide a scientific approach for classifying drug compounds based on their dose/solubility ratio and human intestinal permeability. Therefore in this study a new classification is presented, which is based on a correlation between rat and human intestinal permeability values.In situ ...
Parvin, Zakeri-Milani +3 more
openaire +4 more sources
Paediatric biopharmaceutics classification system: Current status and future decisions
Biopharmaceutical methods are routinely used in the design of medicines to predict in vivo absorption and hence guide the development of new products. Differences in anatomy and physiology of paediatric patients require adaptation of existing biopharmaceutical methods to ensure that in vivo predictions are relevant for this population.
Batchelor, Hannah
openaire +3 more sources
Positioning of Rifampicin in the Biopharmaceutics Classification System (BCS)
Clinical Research and Regulatory Affairs, 2006The position of rifampicin with respect to the biopharmaceutics classification system (BCS) was explored on the basis of its aqueous solubility and intestinal permeability. The aqueous solubility was determined between pH 1 and 7 by the conventional shake-flask method.
T.T. Mariappan, Saranjit Singh
openaire +3 more sources
Advanced Drug Delivery Reviews, 2002
The complexity of multiple species approvals continues throughout the life of a product as post-approval manufacturing changes, as well as all generic versions of approved products, are evaluated for each of the approved target animal species. In comparing product bioavailability across animal species, it is not unusual to observe marked interspecies ...
Marilyn, Martinez +3 more
openaire +4 more sources
The complexity of multiple species approvals continues throughout the life of a product as post-approval manufacturing changes, as well as all generic versions of approved products, are evaluated for each of the approved target animal species. In comparing product bioavailability across animal species, it is not unusual to observe marked interspecies ...
Marilyn, Martinez +3 more
openaire +4 more sources
Biopharmaceutics Drug Disposition Classification System
2022Fil: Bellera, Carolina Leticia. Universidad Nacional de La Plata. Facultad de Ciencas Exactas. Laboratorio de Investigación y Desarrollo de Bioactivos; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata; Argentina. Universidad Nacional de La Plata.
Talevi, Alan, Bellera, Carolina Leticia
openaire +2 more sources
The Biopharmaceutical Classification System of Excipients
Therapeutic Delivery, 2017The increasing number of new chemical entities is bringing new challenges to the field of drug delivery. These drugs present bioavailability issues that are frequently associated with intestinal metabolism or efflux mechanisms. Some excipients, particularly surfactants, have demonstrated a capacity to interfere with these mechanisms, improving drug ...
Teófilo, Vasconcelos +2 more
openaire +2 more sources
Biopharmaceutics classification system
Systematic Reviews in Pharmacy, 2010Biopharmaceutics Classification System (BCS) has provided a mechanistic framework for understanding the concept of drug absorption in terms of permeability and solubility. This article reviews the criteria and issues for classifying drugs according to the BCS.
HV Chavda, CN Patel, IS Anand
openaire +1 more source

